I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research and development, as well as a keen understanding of technological innovation in the industry. Today, we’re diving into the recent developments surrounding Agios Pharmaceuticals and their
In a groundbreaking development for rheumatoid arthritis treatment, Lifordi Immunotherapeutics, a clinical-stage biotech firm headquartered in Burlington, Massachusetts, has successfully raised $112 million in a funding round led by Sanofi Ventures, with continued support from prominent investors
Spinal Muscular Atrophy (SMA), a rare genetic disorder that causes progressive muscle weakness and significant life challenges, has long been a focus of medical research seeking transformative solutions for affected individuals across all ages. A pivotal moment in this journey arrived on November
Diving into the complex world of radiation-induced brain injury (RIBI), we’re thrilled to speak with a leading expert in radiation oncology and neuroimaging. With years of experience in both clinical practice and cutting-edge research, our guest today has dedicated their career to understanding the
In a world where medical advancements have conquered countless diseases, a silent yet deadly threat looms large—drug-resistant fungal infections are claiming millions of lives each year, often with little public attention. These infections strike hardest at the most vulnerable, such as cancer
In a groundbreaking moment for the biotechnology sector, San Diego-based startup Iambic has captured the spotlight by raising an impressive $100 million in Series B financing to propel clinical trials of its AI-discovered cancer drugs, marking a significant milestone for the company. This
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86